NCT05225844 2022-02-07An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced GastrointestinalHarbin Medical UniversityPhase 2 Unknown150 enrolled
NCT03271255 2019-01-23Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)Shenzhen People's HospitalPhase 2 Unknown80 enrolled